TCW Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $298K | Buy |
3,292
+159
| +5% | +$14.6K | ﹤0.01% | 576 |
|
|
2025
Q4 | $282K | Buy |
+3,133
| New | +$297K | ﹤0.01% | 585 |
|
|
2021
Q4 | – | Sell |
-154,167
| Closed | -$21.9K | – | 347 |
|
|
2021
Q3 | $21.9K | Sell |
154,167
-8,194
| -5% | -$1.21M | 0.06% | 102 |
|
|
2021
Q2 | $25.4M | Sell |
162,361
-2,685
| -2% | -$435K | 0.22% | 97 |
|
|
2021
Q1 | $25.6M | Buy |
165,046
+21,012
| +15% | +$3.25M | 0.25% | 92 |
|
|
2020
Q4 | $21.5M | Sell |
144,034
-26,802
| -16% | -$3.79M | 0.19% | 93 |
|
|
2020
Q3 | $22.6M | Buy |
170,836
+4,706
| +3% | +$615K | 0.25% | 88 |
|
|
2020
Q2 | $19.3M | Sell |
166,130
-5,796
| -3% | -$668K | 0.22% | 90 |
|
|
2020
Q1 | $16.9M | Sell |
171,926
-66,326
| -28% | -$8.69M | 0.23% | 85 |
|
|
2019
Q4 | $34.6M | Buy |
238,252
+89,062
| +60% | +$12.3M | 0.38% | 71 |
|
|
2019
Q3 | $19.9M | Buy |
149,190
+127,348
| +583% | +$16.5M | 0.23% | 96 |
|
|
2019
Q2 | $2.5M | Buy |
21,842
+5,707
| +35% | +$668K | 0.03% | 195 |
|
|
2019
Q1 | $2M | Buy |
+16,135
| New | +$1.83M | 0.02% | 209 |
|
|
2017
Q1 | – | Sell |
-15,193
| Closed | -$1.52M | – | 628 |
|
|
2016
Q4 | $1.52M | Sell |
15,193
-51
| -0.3% | -$5.47K | 0.01% | 410 |
|
|
2016
Q3 | $1.92M | Buy |
15,244
+206
| +1% | +$25.5K | 0.01% | 338 |
|
|
2016
Q2 | $1.76M | Buy |
15,038
+2,163
| +17% | +$245K | 0.01% | 352 |
|
|
2016
Q1 | $1.33M | Buy |
12,875
+669
| +5% | +$64.7K | 0.01% | 422 |
|
|
2015
Q4 | $1.22M | Buy |
12,206
+155
| +1% | +$15.2K | 0.01% | 457 |
|
|
2015
Q3 | $1.1M | Buy |
12,051
+103
| +0.9% | +$10.3K | 0.01% | 487 |
|
|
2015
Q2 | $1.27M | Sell |
11,948
-38,883
| -76% | -$4.3M | 0.01% | 480 |
|
|
2015
Q1 | $5.8M | Buy |
50,831
+2,060
| +4% | +$235K | 0.03% | 361 |
|
|
2014
Q4 | $5.37M | Sell |
48,771
-36,462
| -43% | -$3.84M | 0.02% | 380 |
|
|
2014
Q3 | $8.32M | Sell |
85,233
-1,339
| -2% | -$132K | 0.03% | 356 |
|
|
2014
Q2 | $8.73M | Sell |
86,572
-103
| -0.1% | -$10.1K | 0.04% | 361 |
|
|
2014
Q1 | $7.96M | Sell |
86,675
-360
| -0.4% | -$33.2K | 0.03% | 379 |
|
|
2013
Q4 | $7.87M | Buy |
87,035
+824
| +1% | +$71.3K | 0.03% | 383 |
|
|
2013
Q3 | $6.88M | Buy |
86,211
+1,184
| +1% | +$93.2K | 0.03% | 406 |
|
|
2013
Q2 | $6.19M | Buy |
+85,027
| New | +$6.36M | 0.03% | 421 |
|
Other funds holding ZBH
VCM
VPM
TCW Group's ZBH Position: Q1 2026 in Review
TCW Group increased its Zimmer Biomet (ZBH) stake by 5.1% in Q1 2026, buying an estimated $14.6K and bringing the position to 3,292 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #576.
TCW Group first reported a position in ZBH in Q2 2013 and has held it in 28 quarters since. The position peaked at $34.6M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- TCW Group held 3,292 shares of Zimmer Biomet worth $298K as of Q1 2026.
- TCW Group bought 159 Zimmer Biomet shares in Q1 2026, an estimated $14.6K.
- Zimmer Biomet made up ﹤0.01% of TCW Group's portfolio in Q1 2026, its #576 holding.
- TCW Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 28 quarters since.
- TCW Group's Zimmer Biomet position peaked at $34.6M in Q4 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.